Alterity Therapeutics (ATHE) Rent Expense (2017 - 2025)
Alterity Therapeutics (ATHE) posted Rent Expense of $9656.9 for Q4 2025, up 52.96% on a QoQ basis from $6313.3 in Q4 2024, and up 52.96% year-over-year from $6313.3 in Q4 2024.
Analysis
Alterity Therapeutics (ATHE) Rent Expense (2017 - 2025) Analysis & Trends
Alterity Therapeutics has reported Rent Expense for 8 years, with the latest figure at $9656.9 in Q4 2025.
- On a quarterly basis, Rent Expense rose 52.96% year-over-year to $9656.9 in Q4 2025; TTM through Dec 2025 was $37419.3, a 25.09% decrease from a year earlier, with the FY2024 full-year figure at -$6375.4, down 113.9% from the prior year.
- Rent Expense was $9656.9 for Q4 2025 at Alterity Therapeutics, up from $6313.3 in the prior quarter.
- The five-year high for Rent Expense was $24488.5 in Q4 2022, with the low at -$3039.5 in Q4 2023.
- Average Rent Expense over 5 years is $11921.6, with a median of $9656.9 recorded in 2025.
- The sharpest annual moves came in 2023 and 2024: Rent Expense sank 112.41% in 2023, then jumped 307.71% in 2024.
- Over 5 years, Rent Expense stood at $22188.7 in 2021, then grew by 10.36% to $24488.5 in 2022, then tumbled by 112.41% to -$3039.5 in 2023, then surged by 307.71% to $6313.3 in 2024, then jumped by 52.96% to $9656.9 in 2025.
- The last three Rent Expense figures came in at $9656.9 (Q4 2025), $6313.3 (Q4 2024), and -$3039.5 (Q4 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Rental Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Alterity Therapeutics | 72.80 Mn | 72.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 9,656.91 |
| Dec 31, 2024 | 6,313.30 |
| Dec 31, 2023 | -3,039.47 |
| Dec 31, 2022 | 24,488.52 |
| Dec 31, 2021 | 22,188.68 |
| Dec 31, 2019 | 20,712.24 |
| Dec 31, 2018 | 52,902.97 |
| Dec 31, 2017 | 68,141.43 |